Literature DB >> 22070825

Somatic hypermutation leads to diversification of the heavy chain immunoglobulin repertoire in cattle.

Subhash Verma1, Robert Aitken.   

Abstract

The availability of unique variable (VH), diversity (D), and joining (JH) gene segments in the vertebrate germline determines the extent to which a primary immunoglobulin (Ig) repertoire can be generated through combinatorial rearrangement. Although bovine D segments possess unusual properties, the diversity of the primary Ig heavy chain (IgH) repertoire in cattle is restricted by the dominance of a single family of germline VH genes of limited number and diversity. Cattle therefore must employ other diversification strategies in order to generate a functional IgH repertoire, the main candidates being gene conversion and somatic hypermutation. In considering these possibilities, we predicted that if somatic hypermutation was active during B lymphocyte development, the process would introduce nucleotide substitutions to the VDJ exon and also non-coding region lying downstream of the rearranged JH segment. In contrast, our expectation was that gene conversion would show a greater tendency to confine modification to the IgH coding sequence, leaving intron regions substantially unmodified. An analysis of rearranged IgH sequences from cattle of different ages revealed that the diversification of germline sequences could be observed in very young calves and that substitution frequency increased with age. The age-dependent accumulation of mutations was particularly apparent in the second IgH complementarity-determining region (CDR2). Single base substitutions were found to predominate, with purines targeted more frequently than pyrimidines and transitions favoured over transversions. In non-coding regions, mutations were detected at a normalised frequency that was indistinguishable from that observed in CDR2. These data are consistent with a process of IgH diversification driven predominantly by somatic hypermutation.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22070825     DOI: 10.1016/j.vetimm.2011.10.001

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  7 in total

Review 1.  Distinct antibody species: structural differences creating therapeutic opportunities.

Authors:  Serge Muyldermans; Vaughn V Smider
Journal:  Curr Opin Immunol       Date:  2016-02-27       Impact factor: 7.486

2.  Immunogenetic factors driving formation of ultralong VH CDR3 in Bos taurus antibodies.

Authors:  Thaddeus C Deiss; Melissa Vadnais; Feng Wang; Patricia L Chen; Ali Torkamani; Waithaka Mwangi; Marie-Paule Lefranc; Michael F Criscitiello; Vaughn V Smider
Journal:  Cell Mol Immunol       Date:  2017-12-04       Impact factor: 11.530

3.  Hematopoiesis in the equine fetal liver suggests immune preparedness.

Authors:  J M Battista; R L Tallmadge; T Stokol; M J B Felippe
Journal:  Immunogenetics       Date:  2014-09-02       Impact factor: 2.846

4.  Application of circular consensus sequencing and network analysis to characterize the bovine IgG repertoire.

Authors:  Peter A Larsen; Timothy P L Smith
Journal:  BMC Immunol       Date:  2012-09-14       Impact factor: 3.615

5.  Expansion of the preimmune antibody repertoire by junctional diversity in Bos taurus.

Authors:  Jenni Liljavirta; Mikael Niku; Tiina Pessa-Morikawa; Anna Ekman; Antti Iivanainen
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

Review 6.  Diversity in the Cow Ultralong CDR H3 Antibody Repertoire.

Authors:  Jeremy K Haakenson; Ruiqi Huang; Vaughn V Smider
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

7.  The role of the light chain in the structure and binding activity of two cattle antibodies that neutralize bovine respiratory syncytial virus.

Authors:  Jingshan Ren; Joanne E Nettleship; Gemma Harris; William Mwangi; Nahid Rhaman; Clare Grant; Abhay Kotecha; Elizabeth Fry; Bryan Charleston; David I Stuart; John Hammond; Raymond J Owens
Journal:  Mol Immunol       Date:  2019-05-14       Impact factor: 4.407

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.